Background and Purpose-Endothelium-derived hyperpolarizing factor (EDHF)-mediated dilations are potentiated after several pathologies, including ischemia/reperfusion (I/R). However, no study to date has addressed the mechanism by which this potentiation occurs. This study tested the hypothesis that potentiated EDHF-mediated dilations are due to altered endothelial Ca 2ϩ handling after I/R. Methods-Rat middle cerebral arteries (MCAs) were isolated after 2 hours of MCA occlusion and 24 hours of reperfusion (or sham surgery). This model has been previously demonstrated to produce potentiated EDHF-mediated dilations.
V ascular tone may be modulated by several endotheliumderived compounds such as nitric oxide (NO) 1,2 and prostacyclin (prostaglandin I 2 [PGI 2 ]). 3, 4 However, an additional vasorelaxation pathway has subsequently been revealed and termed endothelium-derived hyperpolarizing factor (EDHF) (for review, see Golding et al 5 and Feletou and Vanhoutte 6 ). Since the discovery of the EDHF-dependent mechanism, EDHFdependent dilations have been described with increasing regularity in both the peripheral and cerebral circulations.
In addition, recent studies have described potentiated EDHF-mediated dilations after several pathological conditions such as ischemia/reperfusion (I/R), [7] [8] [9] hypercholesterolemia, 10, 11 and congestive heart failure. 12 With regard to I/R in particular, studies have shown potentiated dilations in response to EDHF-dependent agonists (UTP and A23187) in rat cerebral arteries. 7, 8 After 2 hours of ischemia and 24 hours of reperfusion, the EDHF-mediated component of the dilation was potentiated approximately 7-fold compared with control. 7 Additionally, dog coronary arteries subjected to 1 hour of ischemia and 2 hours of reperfusion also showed evidence of a potentiated EDHF-mediated component. 9 These combined findings from varied pathologies have led to the speculation that EDHF-mediated responses may play an additional role as a compensatory or backup mechanism in certain conditions. However, despite the increasing descriptions of potentiated EDHF-mediated dilations in multiple pathologies, no study to date has addressed the mechanism by which that potentiation occurs.
Although the exact mechanism by which EDHF-mediated dilations are initiated is not completely understood, it appears clear that an elevation of endothelial Ca 2ϩ is necessary. [13] [14] [15] [16] Furthermore, recent data have demonstrated that a specific endothelial Ca 2ϩ threshold exists that, when met, initiates an EDHF-mediated dilation. 17 Thus, agents that increase Ca 2ϩ above the EDHF threshold result in the production of EDHFmediated dilations, whereas those that fail to increase Ca 2ϩ to the threshold do not. Along these lines, one might also expect the potency of EDHF-producing agonists to vary depending on conditions that affect endothelial Ca 2ϩ regulation. For example, one might expect potentiated EDHF-mediated dilations under conditions that favor greater increases in endothelial Ca 2ϩ . Given the critical role of Ca 2ϩ in normal EDHF-mediated dilations, it is reasonable to suspect that alterations in endothelial Ca 2ϩ regulation might account for the potentiated EDHF-mediated dilations after I/R. Therefore, the following studies were designed to evaluate the hypothesis that endothelial Ca 2ϩ regulation is altered after I/R, thus resulting in amplified Ca 2ϩ responses and potentiated dilations for EDHFdependent agonists. It was predicted that endothelial Ca 2ϩ would reach the EDHF-producing threshold at lower agonist concentrations in I/R arteries compared with shams. To test this hypothesis, endothelial Ca 2ϩ was increased via 2 separate receptor systems (P2Y 1 and P2Y 2 purinoceptors) and through a receptor-independent mechanism (Br-A23187) in pressurized rat middle cerebral arteries (MCAs). Selective measurement of endothelial Ca 2ϩ was performed in pressurized MCAs from sham and I/R rats with the use of recently developed fluorescence techniques. 17, 18 Simultaneous measurement of artery diameter permitted the evaluation of endothelial Ca 2ϩ in the vasodilatory responses.
Materials and Methods
All experiments were approved by the Animal Protocol Review Committee at Baylor College of Medicine. A total of 29 male Long-Evans rats were used for these studies (weight, 250 to 350 g). Rats were anesthetized with 3% isoflurane before any procedures.
MCA Occlusion/Reperfusion Surgery
Rats were maintained with 1.5% to 2.5% isoflurane through a nose cone and allowed to breathe freely during surgery. Rats were also treated with 2% lidocaine at the site of surgery before the surgical procedure. Core body temperature was measured rectally and maintained at 37°C with a temperature controller coupled to a heating pad.
The right MCA was occluded for 2 hours, as previously described. 7, 19 In brief, the right carotid artery was exposed in the area of the carotid bifurcation. The external carotid artery was tied off, severed, and retracted for use as a route to introduce the occluding device. The occluding device consisted of a nylon monofilament (Ϸ242 m in diameter) with the tip enlarged and rounded with a small bulb of epoxy. The occluder was introduced into a small hole in the external carotid artery and advanced in a retrograde fashion back to the bifurcation and into the internal carotid artery. The occluder was further advanced toward the circle of Willis until the tip met resistance at the opening of the anterior cerebral artery. This placement of the occluder resulted in occlusion of the right MCA at the point of origin off of the circle of Willis. Note that the occluder did not enter the MCA lumen; rather, it simply blocked the opening. Furthermore, transmission electron microscopy studies have shown that the MCA endothelium remains intact after occlusion/reperfusion in this model. 8 The occluder was left in place for 2 hours before complete removal and restoration of blood flow. Rats were ambulatory before they returned to the animal care facilities. Sham surgeries were the same as above except that the occluder was removed immediately after placement.
Mounting of Pressurized/Perfused Cerebral Arteries
After 24 hours of reperfusion (after occluder removal), rats were anesthetized with isoflurane, and the brain was removed and placed in ice-cold physiological salt solution (PSS). A 2-to 3-mm section of the MCA ipsilateral to the injury was removed and mounted on 2 glass micropipettes within an isolated vessel chamber designed specifically for fluorescence microscopy (Chuel Tech). The chamber was filled with warmed (37°C) Krebs' buffer at a pH of 7.4. The vessel was tested for the absence of leaks by clamping the luminal inflow and outflow tubings and monitoring the pressure from in-line pressure transducers. A constant pressure (Ϸ50 mm Hg) over a 30-second time period indicated a leak-free vessel. Each vessel was then pressurized to a mean pressure of 85 mm Hg, and flow was established through the lumen at a rate of 100 L/min. 18 The artery was allowed to equilibrate for 40 to 60 minutes before the fura 2-AM loading procedure. Sham and I/R arteries developed spontaneous tone during the course of the equilibration period.
Measurement of Endothelial Ca 2؉ in Pressurized/Perfused Arteries
After 40 to 60 minutes of equilibration, an autofluorescence measurement was made of the pressurized artery. The autofluorescence value was later subtracted from the total fluorescence to yield fluorescence resulting purely from fura 2. The endothelium was then selectively loaded with a cell-permeant fluorescent Ca 2ϩ -indicating dye, fura 2-AM, by delivering the dye luminally for 5 minutes. 18 Fura 2-AM (0.67 mol/L) was mixed with 0.02% pluronic F-127 in dimethyl sulfoxide. At the end of the loading period, the fura 2 solution was washed out by perfusing with standard PSS. A period of 15 minutes was allowed after the fura 2-AM washout to allow for complete deesterification of fura 2-AM to fura 2 by endogenous endothelial esterases.
Measurement of endothelial Ca 2ϩ in fura 2-loaded arteries was performed with a system combining a fluorometer and a vessel edge-detection device. The fluorometer (C&L Instruments) used an excitation filter wheel to cycle rapidly between 340, 380, and 360 nm with the use of bandpass filters. A dichroic mirror was used to deflect the varying excitation wavelengths to the artery and allow the resulting fluorescence emission to pass through to a beam splitter. An infrared light source was used to transilluminate the artery for simultaneous measurement of artery diameter. The infrared light also passed through the dichroic mirror to the beam splitter. Approximately 20% of the fluorescence/infrared signal was diverted to a charge-coupled device (CCD) camera with the remaining diverted to a photomultiplier detector. The photomultiplier detector was equipped with a 540/40-nm bandpass filter to selectively measure fura 2 fluorescence without interference from the infrared wavelengths. The image from the CCD was directed to the vessel edge-detector device (Living Systems), where the diameter was measured and output in real time into the fluorescence/Ca 2ϩ measurement. The ratio of 340 to 380 fluorescence (R 340/380 ) was converted to intracellular free Ca 2ϩ ([Ca 2ϩ ] i ) on the basis of the following equation:
where ␤ is the ratio of the 380 fluorescence unbound to bound Ca 2ϩ , R is the R 340/380 , R max is the R 340/380 in saturating Ca 2ϩ conditions, and R min is the R 340/380 in Ca 2ϩ -free conditions. Values for these constants were obtained from a series of in situ calibration curves yielding values as follows: ␤ϭ5.218, R max ϭ2.017, and R min ϭ0.1365. The dissociation constant for fura 2 to Ca 2ϩ (K d ) in intact cerebral arteries was 282 nmol/L. 20
Concentration-Response Curves to Luminal Agents
Concentration-response curves were performed with the use of luminally administered UTP, 2-methylthioadenosine 5Ј-triphosphate (2 MeS-ATP), and Br-A23187. A manifold system was used to substantially reduce the dead volume of the luminal tubing and thus greatly speed the rate of getting the drug from the reservoir to the endothelium. Concentration-response curves to UTP and Br-A23187 were performed in the presence of N G -nitro-L-arginine (L-NAME; 50 mol/L) and indomethacin (10 mol/L) to rule out the effects of NO and PGI 2 formation, respectively. Concentration-response curves to 2 MeS-ATP did not include L-NAME/indomethacin.
Histology
After 24 hours of reperfusion, the brain was evaluated for the presence of ischemic injury with 2,3,5-triphenyltetrazolium chloride (TTC). After removal of the MCA segment, the brain was placed in a rat brain matrix (Braintree Scientific) and sliced into 2-mm coronal sections. The sections were incubated in 2.5% TTC for at least 30 minutes. Areas with profound ischemic injury remained white, whereas viable tissue stained red. 7, 21 Brains were scored on a scale from 0 to 4 as follows: 0, no lesion; 1, small lesion confined to the striatum; 2, lesion largely consuming the striatum; 3, lesion consuming the striatum and involving some cortex; and 4, lesion consuming the striatum and cortex. "I/R" arteries were used only from rats with an injury score of 3 or 4. Note that this reflects stricter inclusion criteria for I/R arteries compared with previous studies, which included animals with scores of 1 through 4. 7,22
Chemicals and Buffer Compositions
All drugs and chemicals were obtained from Sigma with the exceptions of fura 2-AM and pluronic F-127 (TefLabs) and Br-A23187 (Molecular Probes). The Krebs' buffer (PSS) consisted of the following (in mmol/L): 119 NaCl, 4.7 KCl, 21 NaHCO 3 , 1.18 KH 2 PO 4 , 1.17 MgSO 4 , 0.026 EDTA, 1.6 CaCl 2 , and 5.5 glucose. 18 The buffer was bubbled continuously with 20% O 2 /5% CO 2 /balance N 2 to yield a pH of 7.4 at 37°C.
Statistical Methods
Values are reported as meanϮSE. Single measurements between groups were compared with Student's t test. When multiple measurements were performed (such as for a concentration-response curve), a 2-way repeated-measures ANOVA was used to determine whether a statistical difference existed between groups. When group differences did exist, further evaluation of individual differences was performed with a Tukey test. Significance was defined as PϽ0.05.
Changes in artery diameter are reflected by the following equation:
where D drug is the diameter of the artery after administration of an agonist, D base is the resting diameter, and D max is the maximal diameter of the artery (equivalent to Ca 2ϩ -free diameter).
Results
On pressurization (85 mm Hg) and establishment of luminal flow (100 L/min), sham and I/R MCAs developed spontaneous tone over the course of 40 to 60 minutes. The percent tone at the end of the equilibration period was similar between the 2 groups (Table) . The addition of L-NAME/indomethacin resulted in a significant increase in tone in the sham group but not in the I/R group. Tone in the presence of L-NAME/indomethacin was significantly greater in the sham group (38Ϯ3% versus 25Ϯ2% tone; PϽ0.01). I/R MCAs were not further constricted with a constricting agent because of the likely alterations that would result in endothelial Ca 2ϩ . 23 To determine whether altered endothelial Ca 2ϩ responses might account for the potentiated EDHF-mediated dilations after I/R, concentration-response curves to luminal UTP (10
Ϫ5 mol/L) were performed in the presence of L-NAME and indomethacin. Dilations to UTP in the presence of L-NAME/indomethacin have been demonstrated to be EDHF dependent and potentiated after I/R in this preparation. 7, 24 MCA diameter changes and endothelial [Ca 2ϩ ] i were recorded simultaneously in fura 2-loaded arteries for both sham and I/R groups. 
Marrelli
Altered Endothelial Ca 2؉ Regulation After I/RUTP in I/R MCAs compared with shams ( Figure 1, bottom) . In addition, note the potentiated dilation in the I/R MCA at 10 Ϫ6 mol/L UTP (Figure 1, top) . Interestingly, the dilations at 1 mol/L UTP appeared more transient than the corresponding Ca 2ϩ response in the I/R group. These data are summarized in Figure 2 . From Figure 2 , it is evident that while resting Ca 2ϩ was similar between sham and I/R groups (nϭ5 each), UTP produced a significantly greater increase in endothelial Ca 2ϩ in the I/R MCAs for a given concentration of UTP. The horizontal dashed line indicates the Ca 2ϩ threshold (Ϸ340 nmol/L) for initiating an EDHF-mediated dilation from a previous study 17 and the present study (Figure 4 , bottom). Endothelial Ca 2ϩ in response to 1 mol/L UTP in the I/R group exceeds the Ca 2ϩ threshold for EDHF-mediated dilations, whereas Ca 2ϩ from the sham group does not. The dilatory response to UTP was also significantly potentiated in the I/R group. In particular, dilations at 1 mol/L UTP were significantly greater in the I/R group. Although endothelial Ca 2ϩ was considerably higher in the I/R group at 10 mol/L UTP, differences in percent diameter change did not exist between the groups because of maximal dilations that occurred in each group.
To determine whether the potentiated Ca 2ϩ and diameter responses were specific to the receptor system used above, an additional agonist, 2 MeS-ATP, was evaluated. UTP and 2 MeS-ATP operate through 2 separate receptor systems and dilatory mechanisms. UTP stimulates a P2Y 2 purinoceptor that results in an increase in endothelial Ca 2ϩ through an inositol 1,4,5-triphosphate (IP 3 )-dependent mechanism with the subsequent production of NO and EDHF. 24,25 2 MeS-ATP stimulates a P2Y 1 purinoceptor that produces an increase in endothelial Ca 2ϩ in an IP 3 -independent manner with subsequent release of NO alone under normal conditions. [25] [26] [27] Figure 3 represents summary data for concentration-response curves to 2 MeS-ATP (10 Ϫ8 to 10 Ϫ5 mol/L) for sham and I/R MCAs (nϭ4 each). L-NAME and indomethacin were omitted from these experiments to obtain corresponding NOdependent diameter measurements. Similar to the UTPmediated responses, 2 MeS-ATP produced potentiated Ca 2ϩ responses after I/R. Furthermore, the greater Ca 2ϩ response after I/R was accompanied by a potentiated diameter response as well.
On the surface, it would seem paradoxical that diameter at 10 Ϫ8 mol/L UTP was significantly different between groups while endothelial Ca 2ϩ was not. However, there are 2 reasons for this apparent discrepancy. The first is that the measure for Ca 2ϩ has a lower level of precision than that for diameter. Since the measure of endothelial Ca 2ϩ is subject to more variability in measurement, it would require more animals to reach significance. The second part that contributes to this apparent discrepancy is due to the fact that the endothelial [Ca 2ϩ ] i at 10 Ϫ8 mol/L 2 MeS-ATP falls right around the Ca 2ϩ threshold for NO-mediated responses in these arteries (220 nmol/L Ca 2ϩ ). 17 Therefore, increases in endothelial Ca 2ϩ that fail to reach the threshold of 220 nmol/L Ca 2ϩ do not produce an increase in diameter, whereas increases above the threshold do. Importantly, only relatively small increases from baseline in endothelial Ca 2ϩ are necessary to reach that threshold. Furthermore, because a threshold exists, a linear relationship between Ca 2ϩ and diameter would not be expected. Rather, significant increases in diameter would be expected once Ca 2ϩ entered the threshold range. In this way, relatively small changes in endothelial Ca 2ϩ (that do not reach statistical difference) could result in a more amplified difference in diameter responses (that does reach statistical difference).
To determine whether the potentiated Ca 2ϩ and diameter responses were dependent on receptor-mediated events, concentration-response curves were conducted with Br-A23187 in the presence of L-NAME and indomethacin. Br-A23187 is a nonfluorescent Ca 2ϩ ionophore used to increase endothelial [Ca 2ϩ ] i through a non-receptordependent process. Concentration-response curves to luminally delivered Br-A23187 (1 to 6 mol/L) resulted in a significantly greater increase in endothelial Ca 2ϩ for a given concentration of Br-A23187 (Figure 4, top; nϭ4 each) .
Data from individual experiments with Br-A23187 and UTP were combined and plotted as percent diameter versus endothelial Ca 2ϩ (Figure 4 , bottom). The data derived from UTP and Br-A23187 did not differ from each other and were therefore combined into 1 plot. Two things are apparent from these data. 
Discussion
A growing number of recent studies have reported upregulated EDHF-mediated dilations after a variety of pathological conditions, including I/R, 7-9 hypercholesterolemia, 10, 11 and congestive heart failure. 12 However, none of these studies has addressed the mechanism by which EDHF-mediated responses are potentiated. Presumably, this lack of data regarding the potentiated EDHF mechanism has been due in part to 
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Altered Endothelial Ca 2؉ Regulation After I/R 2289 the incomplete understanding of the mechanism by which EDHF-mediated responses occur. Although there is still considerable debate regarding the identity of EDHF (or whether EDHF is a factor per se), it is generally accepted that EDHF-mediated responses are initiated by an increase in endothelial Ca 2ϩ . [13] [14] [15] [16] Furthermore, recent data from this laboratory have demonstrated that an endothelial Ca 2ϩ threshold exists that, when met, initiates an EDHF-mediated dilation. 17 The threshold for EDHFmediated dilations is higher than that for NO-mediated dilations (340 versus 220 nmol/L), explaining why NOmediated responses are typically found to precede EDHFmediated responses. Additionally, it was shown that a normally non-EDHF-producing agonist (2 MeS-ATP) could elicit an EDHF-mediated response in conditions in which 2 MeS-ATP-mediated endothelial Ca 2ϩ responses were augmented in order to reach the critical Ca 2ϩ threshold. 17 Thus, it appears that endothelial [Ca 2ϩ ] i critically regulates the EDHFmediated response. In the present study it was hypothesized that an augmented endothelial Ca 2ϩ response accounts for the potentiated EDHF-mediated response after I/R. This hypothesis was addressed by simultaneously measuring endothelial Ca 2ϩ and artery diameter in pressurized arteries. Two separate and distinct endothelial purinoceptors (P2Y 2 and P2Y 1 ) were used in addition to a Ca 2ϩ ionophore (Br-A23187) in order to increase endothelial Ca 2ϩ . UTP, which is selective for P2Y 2 purinoceptors, has been demonstrated to produce both NO-and EDHF-mediated responses in the rat MCA. 7,24 2 MeS-ATP, which is selective for P2Y 1 purinoceptors, produces dilations through an exclusively NO-dependent mechanism. 7, 27 Release of Ca 2ϩ through the P2Y 2 purinoceptor is believed to depend on the production of IP 3 , whereas that of the P2Y 1 purinoceptor does not. 25, 26 Br-A23187 elevates endothelial Ca 2ϩ in a receptorindependent fashion, thus bypassing any effect of receptor number or coupling.
Potentiated endothelial Ca 2ϩ responses were found with the use of both receptor-dependent and -independent mechanisms after I/R. The augmented Ca 2ϩ release found in the present study with both UTP and 2 MeS-ATP might suggest either (1) upregulation of both P2Y 1 and P2Y 2 purinoceptors, (2) potentiation of a common mechanism between the 2 receptor systems, or (3) potentiation of the Ca 2ϩ response downstream of receptor stimulation. However, the additional finding of potentiated Ca 2ϩ responses with the Ca 2ϩ ionophore (Br-A23187) suggests that the potentiation of the Ca 2ϩ response occurs downstream of the receptors. Since increased Ca 2ϩ responses were found with receptor-dependent mechanisms as well as with receptor-independent mechanisms, it would appear that the potentiated Ca 2ϩ is due to more fundamental changes in Ca 2ϩ handling. For instance, there could be a greater increase of [Ca 2ϩ ] i (from internal stores or from external sources), or there could be a reduced removal of [Ca 2ϩ ] i (to internal stores or extrusion across the plasma membrane) after I/R. Either one or both of the above possibilities would result in augmented Ca 2ϩ responses. On the basis of the aforementioned findings, it would be tempting to conclude that the effects of I/R appear to exclude the possibility of greater Ca 2ϩ release from internal stores.
The reasoning behind such a conclusion would be based on the assumptions that Br-A23187 acts purely as a direct mediator of Ca 2ϩ influx 28 and that the 2 MeS-ATP response does not involve an IP 3 -mediated Ca 2ϩ increase. 26 However, such a conclusion might be incorrect for the following 2 reasons. First, in addition to its ionophoretic properties, Br-A23187 has been suggested to stimulate Ca 2ϩ entry through store-operated Ca 2ϩ channels secondary to depletion of internal store Ca 2ϩ . 29 This release of Ca 2ϩ from internal stores may be due to the ability of Br-A23187 to promote the liberation of inositol phosphates such as IP 3 . 30 Second, while 2 MeS-ATP does not appear to involve a significant IP 3 -dependent mechanism under normal circumstances, one cannot assume that IP 3 is not involved in pathological circumstances. Thus, while the present data demonstrate significant alterations in Ca 2ϩ handling after I/R, further studies will be needed to identify where that alteration occurs.
One additional possibility that could contribute to the potentiated dilations after I/R is that of Ca 2ϩ sensitivity. Although the aforementioned data clearly demonstrate that potentiated Ca 2ϩ responses occur, it is possible that an increased Ca 2ϩ sensitivity could also contribute to the potentiated dilations. To evaluate the possibility of altered Ca 2ϩ sensitivity, percent diameter change was plotted against endothelial [Ca 2ϩ ] i (produced by various concentrations of UTP and Br-A23187). This plot demonstrates the sharp transition between no dilation and maximal dilation characteristic of these EDHF-mediated responses. Furthermore, it is clear that there is no significant leftward shift of the curve (which would indicate increased Ca 2ϩ sensitivity) after I/R. Thus, the data are suggestive that increased Ca 2ϩ sensitivity does not play a measurable role in the potentiated EDHFmediated dilations. However, given the inherent limitations of the bioassay system, one cannot completely rule out the possibility of multiple offsetting factors (such as in the vascular reactivity to EDHF) downstream of Ca 2ϩ . In summary, potentiated EDHF-mediated dilations after I/R appear to result from augmented endothelial Ca 2ϩ responses. These augmented Ca 2ϩ responses are not receptor dependent but rather appear to result from a more fundamental alteration in endothelial Ca 2ϩ regulation. Additional studies will be required to determine the specific mechanism by which endothelial Ca 2ϩ regulation is altered.
